title: [Psycho-oncological aspects of malignant melanoma. A systematic review from 1990-2008].
abstract: METHODS
  Despite the increasing prevalence of malignant melanoma, psychosocial aspects have found little attention. A systematic review was conducted in order to identify psycho-oncological articles on patients with malignant melanoma.
  
  
  RESULTS
  Out of a total of 31 studies, 12 examine quality of life in malignant melanoma patients and 6 studies monitor quality of life in the course of therapy. Most studies originate from English-speaking countries (USA, UK, AU); few German studies have been published. Methodological limitations of the studies include cross-sectional assessment, unreported return rate, small sample sizes and comparability (heterogeneous or non-standardized psychosocial measures).
  
  
  CONCLUSIONS
  In addition to the tumor stage, psychosocial characteristics (coping with disease, social support) have a substantial effect on quality of life. Results from psychotherapy trials with malignant melanoma patients are encouraging. Given the overall high survival rates of malignant melanoma, quality of life and needs for care of long-term survivors need to be assessed.
authors.affiliation: Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie, Universitätsmedizin Mainz, Untere Zahlbacher Str. 8, 55131, Mainz. Beutel@Psychosomatik.Klinik.Uni-Mainz.de
authors.forename: M E
authors.initials: ME
authors.lastname: Beutel
authors.forename: M
authors.initials: M
authors.lastname: Blettner
authors.forename: S
authors.initials: S
authors.lastname: Fischbeck
authors.forename: C
authors.initials: C
authors.lastname: Loquay
authors.forename: A
authors.initials: A
authors.lastname: Werner
authors.forename: H
authors.initials: H
authors.lastname: Marian
mesh_terms: D015897:Comorbidity; D006801:Humans; D038622:Internationality; D008545:Melanoma / Q000453:epidemiology* / Q000523:psychology*; D001523:Mental Disorders / Q000453:epidemiology* / Q000523:psychology*; D015995:Prevalence; D011788:Quality of Life; D012878:Skin Neoplasms / Q000453:epidemiology* / Q000523:psychology*
references.citation: J Am Acad Dermatol. 2005 Aug;53(2):224-9
references.pmid: 16021114
references.citation: Psychooncology. 2004 Aug;13(8):526-36
references.pmid: 15295774
references.citation: Hautarzt. 2008 Jun;59(6):484-91
references.pmid: 18478195
references.citation: J Cutan Med Surg. 2004 Sep-Oct;8(5):303-9
references.pmid: 15868284
references.citation: N Engl J Med. 2001 Mar 29;344(13):961-6
references.pmid: 11274622
references.citation: Ann Oncol. 2005 May;16(5):805-16
references.pmid: 15817599
references.citation: Psychosomatics. 1999 May-Jun;40(3):239-50
references.pmid: 10341537
references.citation: Support Care Cancer. 2003 May;11(5):304-12
references.pmid: 12720074
references.citation: J Clin Oncol. 1999 Jul;17(7):2256-63
references.pmid: 10561283
references.citation: J Dtsch Dermatol Ges. 2004 Feb;2(2):105-10
references.pmid: 16279244
references.citation: Melanoma Res. 2002 Oct;12(5):505-11
references.pmid: 12394193
references.citation: Psychooncology. 1999 Jan-Feb;8(1):27-35
references.pmid: 10202780
references.citation: Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1969-76
references.pmid: 17035407
references.citation: Hautarzt. 2004 Aug;55(8):735-45
references.pmid: 15241519
references.citation: Br J Cancer. 2006 Feb 27;94(4):492-8
references.pmid: 16449995
references.citation: J Clin Oncol. 2007 Dec 20;25(36):5698-703
references.pmid: 18089864
references.citation: Eur J Surg Oncol. 2007 Aug;33(6):776-82
references.pmid: 17300914
references.citation: J Behav Med. 2006 Oct;29(5):419-34
references.pmid: 16855870
references.citation: Psychother Psychosom Med Psychol. 2003 Jun;53(6):258-66
references.pmid: 12813660
references.citation: Qual Life Res. 1993 Jun;2(3):193-203
references.pmid: 8401455
references.citation: Arch Gen Psychiatry. 2003 Jan;60(1):100-3
references.pmid: 12511177
references.citation: Psychooncology. 2007 Apr;16(4):287-94
references.pmid: 16858669
references.citation: Cancer. 2003 Aug 15;98(4):854-64
references.pmid: 12910531
references.citation: Int J Cancer. 2000 May 20;89(3):271-9
references.pmid: 10861504
references.citation: Psychosom Med. 2007 Sep-Oct;69(7):667-74
references.pmid: 17766690
references.citation: J Cancer Surviv. 2007 Mar;1(1):87-97
references.pmid: 18648948
references.citation: Br J Cancer. 2000 Dec;83(11):1448-53
references.pmid: 11076652
references.citation: Z Psychosom Med Psychother. 2009;55(4):365-81
references.pmid: 20229484
references.citation: J Investig Dermatol Symp Proc. 2004 Mar;9(2):152-9
references.pmid: 15083783
references.citation: J Clin Oncol. 2001 Jun 1;19(11):2844-50
references.pmid: 11387356
references.citation: Psychooncology. 1999 Jan-Feb;8(1):14-26
references.pmid: 10202779
references.citation: BMC Cancer. 2006 Apr 18;6:95
references.pmid: 16620390
references.citation: J Clin Oncol. 2004 Mar 15;22(6):1118-25
references.pmid: 15020614
references.citation: Lancet Oncol. 2005 Aug;6(8):608-21
references.pmid: 16054572
references.citation: J Psychosom Res. 2007 Jul;63(1):9-15
references.pmid: 17586333
references.citation: J Psychosom Res. 2005 Jan;58(1):19-27
references.pmid: 15771866